Jennifer Litton, MD
Advertisement
Articles by Jennifer Litton, MD
Not only are PARP inhibitors proving to be an efficacious treatment for patients with metastatic breast cancer, but they're also improving quality of life, too.
Advertisement
Latest Updated Articles
Benefits of PARP Inhibitor Use in Breast CancerPublished: January 11th 2019 | Updated:
PARP Inhibitors Improve Outcomes, QOL in Breast CancerPublished: May 17th 2018 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
When Are TKIs Too Aggressive for a Patient With Renal Cell Carcinoma?
2
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer?
3
Real-World Data Favor GLP-1 vs Aspirin in Colorectal Cancer Prevention
4
Linking Patient Experience With Next Steps in Renal Cell Carcinoma
5